Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Mitchell

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Allergy & Rhinology (Providence, R.I.)|January 24, 2013
The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010David A Swender, Leah R Chernin, Chris Mitchell, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
British Journal of Haematology|February 3, 2005
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorderEmily Carpenter, Veronica Valverde-Garduno, Alex Sternberg, et al.
Bone Marrow Transplantation|June 13, 2019
Hyperhydration is not necessary for high-dose melphalan in stem cell transplantationMidori Nakagaki, Elise Button, Amy Keating, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
OpenArm 2.0: Automated Segmentation of 3D Tissue Structures for Multi-Subject Study of Muscle Deformation DynamicsYonatan Nozik, Laura A Hallock, Daniel Ho, et al.
The Lancet. Oncology|February 12, 2013
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Rachel Wade, et al.
Industrial & Engineering Chemistry Research|August 9, 2022
Mechanistic Insight Into the Application of Alumina-Supported Pd Catalysts for the Hydrogenation of Nitrobenzene to AnilineClément G A Morisse, Annelouise M McCullagh, James W Campbell, et al.
Emerging Infectious Diseases|April 3, 2002
HIV prevalence in a gold mining camp in the Amazon region, GuyanaCarol J Palmer, Lloyd Validum, Bernard Loeffke, et al.
British Journal of Haematology|February 3, 2009
Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?G Malcolm Taylor, Sue Richards, Rachel Wade, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Allergy & Rhinology (Providence, R.I.)|January 24, 2013
The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010David A Swender, Leah R Chernin, Chris Mitchell, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
British Journal of Haematology|February 3, 2005
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorderEmily Carpenter, Veronica Valverde-Garduno, Alex Sternberg, et al.
Bone Marrow Transplantation|June 13, 2019
Hyperhydration is not necessary for high-dose melphalan in stem cell transplantationMidori Nakagaki, Elise Button, Amy Keating, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
OpenArm 2.0: Automated Segmentation of 3D Tissue Structures for Multi-Subject Study of Muscle Deformation DynamicsYonatan Nozik, Laura A Hallock, Daniel Ho, et al.
The Lancet. Oncology|February 12, 2013
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Rachel Wade, et al.
Industrial & Engineering Chemistry Research|August 9, 2022
Mechanistic Insight Into the Application of Alumina-Supported Pd Catalysts for the Hydrogenation of Nitrobenzene to AnilineClément G A Morisse, Annelouise M McCullagh, James W Campbell, et al.
Emerging Infectious Diseases|April 3, 2002
HIV prevalence in a gold mining camp in the Amazon region, GuyanaCarol J Palmer, Lloyd Validum, Bernard Loeffke, et al.
British Journal of Haematology|February 3, 2009
Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?G Malcolm Taylor, Sue Richards, Rachel Wade, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
Pageof 8